ESC Premium Access

Atrial fibrillation in heart failure: pharmacological or ablation therapy? – discussion.

Presentation

2 more presentations in this session

Atrial fibrillation in heart failure: optimal pharmacological management.

Speaker: Professor J. Nielsen (Aarhus N, DK)

Thumbnail

Atrial fibrillation in heart failure: when to consider ablation therapy (and when it is too late).

Speaker: Professor K. Kuck (Hamburg, DE)

Thumbnail

Access the full session

Atrial fibrillation in heart failure: pharmacological or ablation therapy?

Speakers: Professor J. Nielsen, Professor K. Kuck
Thumbnail

About the event

Image

ESC Congress 2021 - The Digital Experience

27 August - 30 August 2021

Sessions Presentations

Related content

ESC Premium Access

Choosing wisely: ablation or medication for rhythm control in atrial fibrillation – discussion.

27 August 2021

ESC Premium Access

Ablation or amiodarone for HFrEF patients with atrial fibrillation?

27 August 2021

ESC Premium Access

Endotrophin is significantly associated with disease severity and increased risk of adverse outcome in HFpEF but not in HFrEF patients

27 August 2021

This platform is supported by

logo Novo Nordisk